Pin Wang

Pin Wang is a Full Professor at USC, holding this position since December 2013, with a research focus on immunobioengineering. Wang's work aims to employ engineering principles to understand the immune system in both health and disease, with the development of novel immunotherapies as a key objective. Ongoing projects include engineering virus-derived vectors for vaccine delivery, optimizing chimeric antigen receptor-based cellular immunotherapies, utilizing immune cells for targeted drug delivery, and enhancing adeno-associated virus-based gene delivery systems. In addition to the role at USC, Wang is the Chief Scientific Officer at Simcere Pharmaceutical Group since September 2019. Educational accomplishments include a PhD in Bioengineering from Caltech and a BS in Materials Science and Engineering from the University of Science and Technology of China.